Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride (Q46801541)

25 December 2017

title

Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride (English)

1 reference

25 December 2017

0 references

Amani Eltayb

1

1 reference

25 December 2017

Marie-Louise G Wadenberg

series ordinal

2

1 reference

25 December 2017

Björn Schilström

series ordinal

3

1 reference

25 December 2017

Torgny H Svensson

series ordinal

4

1 reference

25 December 2017

publication date

12 November 2005

1 reference

25 December 2017

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

25 December 2017

volume

372

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

195-202

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00210-005-0014-5

exact match

0 references

cites work

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1007%2FS00210-005-0014-5

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-005-0014-5

Update on the clinical efficacy and side effects of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-005-0014-5

The frontal lobes and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-005-0014-5

Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats

21 January 2018

1 reference

12 December 2020

Atypical antipsychotic-like effect of AMPA receptor antagonists in the rat.

1 reference

12 December 2020

N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.

1 reference

12 December 2020

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

12 December 2020

Topiramate antagonizes MK-801 in an animal model of schizophrenia

1 reference

12 December 2020

The treatment of negative symptoms: pharmacological and methodological issues

1 reference

12 December 2020

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

1 reference

12 December 2020

Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa

1 reference

12 December 2020

Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.

1 reference

12 December 2020

A new computer-assisted two-way avoidance conditioning equipment for rats: behavioral and pharmacological validation.

1 reference

12 December 2020

Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line ‘Depressed’ Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects

1 reference

12 December 2020

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

12 December 2020

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.

1 reference

12 December 2020

Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?

1 reference

12 December 2020

The catalepsy test: its ups and downs

1 reference

12 December 2020

Antiepileptic drugs in schizophrenia: a review

1 reference

12 December 2020

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

12 December 2020

The current status of the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Topiramate and psychiatric adverse events in patients with epilepsy

1 reference

12 December 2020

Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder

1 reference

12 December 2020

Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission

1 reference

12 December 2020

Topiramate titration and tolerability

1 reference

12 December 2020

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

12 December 2020

Role of serotonin in the action of atypical antipsychotic drugs

1 reference

12 December 2020

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

1 reference

12 December 2020

Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia

1 reference

12 December 2020

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

1 reference

12 December 2020

Regulation of medial prefrontal cortex dopamine by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptors

1 reference

12 December 2020

Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study

1 reference

12 December 2020

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events

1 reference

12 December 2020

Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.

1 reference

12 December 2020

Acute psychotic symptoms induced by topiramate

1 reference

12 December 2020

Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats

1 reference

12 December 2020

Pharmacotherapy for schizophrenia and co-occurring substance use disorders

1 reference

12 December 2020

The effects of topiramate and sex hormones on energy balance of male and female rats

1 reference

12 December 2020

An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action

1 reference

12 December 2020

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

12 December 2020

Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat.

1 reference

12 December 2020

Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

1 reference

12 December 2020

Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication.

1 reference

12 December 2020

Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum

1 reference

12 December 2020

Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.

1 reference

12 December 2020

Topiramate for reversing atypical antipsychotic weight gain

1 reference

12 December 2020

Behavioural effects of the newer antiepileptic drugs: an update

1 reference

12 December 2020

Antipsychotic-like effect of the AMPA receptor antagonist LY326325 as indicated by suppression of conditioned avoidance response in the rat.

1 reference

12 December 2020

Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine.

1 reference

12 December 2020

Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral, but not the dorsal, striatum of the rat.

1 reference

12 December 2020

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

1 reference

12 December 2020

10.1007/S00210-005-0014-5

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16284783

1 reference

25 December 2017